COMP <GO>
LYB vs LIN // EV/EBITDA & P/E VALUATION
LyondellBasell Industries NV Ordinary Shares Class A (Netherlands) (NYSE) VS. Linde plc (NASDAQ) • 15-METRIC TALLY: LYB 3
— LIN 11
■ METRIC PARITY
LAST: $68.64 (+5.00%) • MKT CAP: $21.12B
valuation
—
LAST: $514.24 (+2.20%) • MKT CAP: $231.94B
valuation
18.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LYB VS. LIN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LYB | LIN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.50% | 41.00% | -32.50 | LIN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.50% | 13.10% | -15.60 | LIN | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.82% | 2.19% | -0.37 | LIN | /fcf-yield <GO> |
| Operating Margin | -1.40% | 26.30% | -27.70 | LIN | /operating-margins <GO> |
| Net Profit Margin | -2.40% | 20.30% | -22.70 | LIN | /net-margins <GO> |
| Revenue Growth (YoY) | -9.70% | 3.00% | -12.70 | LIN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 8.35% | 1.21% | +7.14 | LYB | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.07 | 3.93 | -1.86 | LIN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | LIN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.90% | +0.20 | LIN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 68.1 | 69.3 | -1.22 | LIN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.01 | +0.04 | LYB | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.0x | 31.2x | -8.20 | LYB | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $21.12B | $231.94B | -$210.83B | LIN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LYB REV | LIN REV | LYB GROSS % | LIN GROSS % | LYB FCF | LIN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $30.15B | $33.99B | 8.5% | 44.0% | $384.0M | $5.09B |
| FY 2024 | $33.39B | $33.01B | 13.9% | 44.0% | $1.98B | $4.93B |
| FY 2023 | $33.34B | $32.85B | 44.0% | 44.0% | $3.44B | $7.83B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LYB // BETA 1.05
LIN // BETA 1.01